Press Releases

09/01 Tecan to present at upcoming Investor Conferences GL
09/01 Tecan reports return to sales growth and strong order entry in the second half of 2025 GL
04/12 Changes to Tecan’s Board of Directors proposed to shareholders at the upcoming Annual General Meeting 2026 GL
02/12 Tecan expands robotic workcell offering with acquisition of Wako Automation assets GL
17/11 CFO Tania Micki to leave Tecan for new role in 2026 GL
05/11 Inside ELRIG Drug Discovery 2025: automation, AI and human-relevant models AQ
13/25/13 Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook GL
18/25/18 Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control AQ
10/25/10 Tecan announces change of leadership in the Partnering Business division GL
14/25/14 Tecan issues CHF 150 million straight bond GL
12/25/12 Tecan : Half Year Results 2025 PU
12/25/12 Tecan reports solid financial results for the first half of 2025 and confirms its outlook for full year 2025 GL
05/25/05 Tecan schedules conference call on August 12th to discuss half year 2025 financial results GL
10/25/10 Tecan announces CEO transition as part of succession planning GL
21/25/21 Tecan : HP expands collaboration with Tecan, launching a new digital dispenser for single-cell and low volume applications PU
12/25/12 Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025 GL
25/25/25 BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours BU
10/25/10 Tecan reports key outcomes from Annual General Meeting 2025 GL
10/25/10 Tecan reports key outcomes from Annual General Meeting 2025 AQ
08/25/08 Tecan : IBL International collaborates with Grifols on advanced biomarker panels PU
03/25/03 Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits BU
18/25/18 Tecan publishes agenda for the Annual General Meeting 2025 AQ
18/25/18 Tecan publishes agenda for the Annual General Meeting 2025 GL
12/25/12 Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions GL
05/25/05 Tecan schedules conference call on March 12 to discuss Full-Year 2024 Financial Results AQ
No results for this search